In-vitro modelling of the bactericidal activity of teicoplanin versus flucloxacillin as used in surgical prophylaxis, against Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 4, 1997, Pages 477-481

  Steer, J A ^a   Hill, G B ^a   Robbins, M J ^a   Newton, J C ^a   Wilson, A P R ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCLOXACILLIN; TEICOPLANIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; SERUM; STAPHYLOCOCCUS AUREUS; SURGERY;

EID: 0030898086     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.4.477     Document Type: Article

References (20)

1. Burke, J. F. (1961). The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 50, 161-8.
2. Classen, D. C., Evans, R. S., Pestotnik, S. L, Horn, S. D., Menlove, R. L. & Burke, J. P. (1992). The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New England Journal of Medicine 326, 281-6.
3. Bailey, E. M., Rybak, M. J. & Kaatz, G. W. (1991). Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin. Antimicrobial Agents and Chemotherapy 35, 1089-92.
4. Chambers, H. F. & Kennedy, S. (1990). Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy 34, 510-4.
5. Wilson, A. P. R., Felmingham, D., Grüneberg, R. N., Treasure, T. & Sturridge, M. F. (1988). Contamination of blood during cardiopulmonary bypass: the effect of antibiotic prophylaxis. Journal of Hospital Infection 12, 35-42.
6. Wilson, A. P. R., Treasure, T., Sturridge, M. F. & Grüneberg, R. N. (1986). Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice. Thorax 41, 396-400.
7. Wilson, A. P. R., Taylor, B., Treasure, T., Grüneberg, R. N., Patton, K., Felmingham, D. et al. (1988). Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. Journal of Antimicrobial Chemotherapy 21, 201-12.
8. Wilson, A. P. R., Shankar, S., Felmingham, D., Treasure, T. & Grüneberg, R. N. (1989). Serum and tissue levels of teicoplanin during cardiac surgery: the effect of a high dose regimen. Journal of Antimicrobial Chemotherapy 23, 613-7.
9. Steer, J. A., Papini, R. P. G., Wilson, A. P. R., Dhillon, S., Hichens, M. F., McGrouther, D. A. et al. (1996). Pharmacokinetics of a single dose of teicoplanin in burn patients. Journal of Antimicrobial Chemotherapy 37, 545-53.
10. Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research, 2nd edn. Blackwell Scientific Publications, Oxford.
11. Maple, P. A. C., Hamilton-Miller, J. M. T. & Brumfitt, W. (1989). Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP721 and DuP105 against methicillin and gentamicin resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 23, 517-25.
12. Neu, H. C. & Labthavikul, P. (1983). In vitro activity of teichomycin compared with those of other antibiotics. Antimicrobial Agents and Chemotherapy 24, 425-8.
13. Bryan, L. E. & Godfrey, A. J. (1991). β-lactam antibiotics: mode of action and bacterial resistance. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), p. 614. Williams & Wilkins, Baltimore, MD.
14. Besnier, J. M. & Choutet, P. (1995). Medical treatment of infective endocarditis: general principles. European Heart Journal 16,Suppl. B, 72-4.
15. Sutherland, R., Croydon, E. A. P. & Rolinson, G. N. (1970). Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin. British Medical Journal iv, 455-60.
16. Greenberg, R. N. & Benes, C. A. (1990). Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus. Journal of Infectious Diseases 161, 1036-7.
17. Wilson, A. P. R., Treasure, T., Grüneberg, R. N., Sturridge, M. F. & Ross, D. N. (1988). Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. Journal of Antimicrobial Chemotherapy 21, 213-23.
18. Antrum, R. M., Galvin, K., Gorst, K., Thornton, C. A., Lansdown, M. & Kester, R. C. (1992). Teicoplanin vs cephradine and metronidazole in the prophylaxis of sepsis following vascular surgery: an interim analysis of an ongoing trial. European Journal of Surgery, Suppl. 567, 43-6.
19. Mollan, R. A. B., Haddock, M. & Webb, C. H. (1992). Teicoplanin vs cepnamandole for antimicrobial prophylaxis in prosthetic joint implant surgery: (preliminary results). European Journal of Surgery, Suppl. 567, 19-21.
20. Periti, P., Stringa, G., Donati, L, Mazzei, T., Mini, E. & Novelli, A. (1992). Teicopianin: its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. European Journal of Surgery, Suppl. 567, 3-8.